Home/Filings/4/0000950170-24-113344
4//SEC Filing

Apeiron Presight Capital Fund II, L.P. 4

Accession 0000950170-24-113344

CIK 0001194833other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 6:22 PM ET

Size

12.7 KB

Accession

0000950170-24-113344

Insider Transaction Report

Form 4
Period: 2024-07-01
Transactions
  • Sale

    Ordinary Shares

    2024-10-02$0.33/sh90,806$29,966125,996,580 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
  • Sale

    Ordinary Shares

    2024-10-03$0.29/sh180,707$52,40593,469,320 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
  • Sale

    Ordinary Shares

    2024-10-04$0.28/sh557$15693,369,060 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
Holdings
  • Ordinary Shares

    (indirect: By Apeiron Investment Group Ltd.)
    183,121,441
Transactions
  • Sale

    Ordinary Shares

    2024-10-03$0.29/sh180,707$52,40593,469,320 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
  • Sale

    Ordinary Shares

    2024-10-02$0.33/sh90,806$29,966125,996,580 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
  • Sale

    Ordinary Shares

    2024-10-04$0.28/sh557$15693,369,060 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
Holdings
  • Ordinary Shares

    (indirect: By Apeiron Investment Group Ltd.)
    183,121,441
Transactions
  • Sale

    Ordinary Shares

    2024-10-03$0.29/sh180,707$52,40593,469,320 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
  • Sale

    Ordinary Shares

    2024-10-02$0.33/sh90,806$29,966125,996,580 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
  • Sale

    Ordinary Shares

    2024-10-04$0.28/sh557$15693,369,060 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
Holdings
  • Ordinary Shares

    (indirect: By Apeiron Investment Group Ltd.)
    183,121,441
Footnotes (3)
  • [F1]Includes Ordinary Shares represented by American Depositary Shares.
  • [F2]The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron Investment Group Ltd. ("Apeiron") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities.
  • [F3]The reportable securities are held by Apeiron. Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.

Documents

1 file

Issuer

BIONOMICS LTD/ADR

CIK 0001194833

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001840676

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 6:22 PM ET
Size
12.7 KB